Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by scarlet1967on Oct 17, 2021 1:48pm
248 Views
Post# 34015603

Polytechnique

Polytechnique

Lvesque ,  President and CEO of Theratechnologies , talk to us about the revitalization and challenges of the pharmaceutical sector.

 

 

Polytechnique Montral is a flagship of engineering in Qubec, and is also one of Canada’s leading engineering educational and research institutions. Since its establishment in 1873, Polytechnique Montral has trained nearly 50,000 engineers, specialists, and researchers.

 

Polytechnique is a key player in Qubec’s engineering and innovation sector, in addition to being a partner of choice for a number of innovative businesses in Qubec, elsewhere in Canada and all over the world.

 

https://www.polymtl.ca/calendrier/en/events/online-matin-alumni-de-poly-paul-levesque-theratechnologies?start=1634644800&end=1634650200

<< Previous
Bullboard Posts
Next >>